Finally, in July 2013, the first SuperPATH Hip replacement in Australia was performed in Nepean Private Hospital, Sydney. Since then, SuperPATH has enjoyed excellent success. By 2016 and over 300 SuperPATH cases, the results of very first 100 SuperPATH surgeries (the so called ‘learning Curve’) were published in a peer reviewed journal with excellent results and a very low complication rate (Qurashi et al, SuperPATH Minimally Invasive Total Hip Arthroplasty – An Australian Experience JISRF • Reconstructive Review • Vol. 6, No. 2, July 2016).
By 2025, and over two thousand SuperPATH cases later. the functional results remain excellent with the complication / revision profile very low and well below the expected benchmark rates in the National Joint Replacement Registry. In particular, the rate of infection and dislocation are extremely low compared to expected benchmark rates. This includes patients of all shapes and sizes including in very obese patients, often not considered candidates for minimally invasive methods, but suitable for SuperPATH.
This is very encouraging and whilst long term results beyond 12 years are yet to be seen, based on current 12 year results, we anticipate these to continue to be nothing short of excellent. The influence of technique on results i.e., those seen in the short to early mid-term, are impressive.
Associate Professor Qurashi is also a participant in the Australian National Joint Register (AOANJRR) and the Arthroplasty Clinical Outcomes Register (ACORN) register which are the essential tools of measuring performance and results of Joint Replacement Surgery in Australia.
Results in Australia:
More about SuperPATH please call 1300 364 061